![Will Greenleaf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Will Greenleaf is the founder of Protillion Biosciences, Inc. He is also the founder of Epinomics, Inc.
Posizioni attive di Will Greenleaf
Società | Posizione | Inizio |
---|---|---|
Epinomics, Inc.
![]() Epinomics, Inc. Packaged SoftwareTechnology Services Epinomics, Inc. provides decoding programming of genome to drive personalized medicine. The company was founded by Paul Giresi, Fergus Chan, Howard Y. Chang and Will Greenleaf and is headquartered in Menlo Park, CA. | Fondatore | - |
Precedenti posizioni note di Will Greenleaf
Società | Posizione | Fine |
---|---|---|
Protillion Biosciences, Inc.
![]() Protillion Biosciences, Inc. BiotechnologyHealth Technology Protillion Biosciences, Inc. is a company based in Burlingame, CA that was founded in 2019 by Will Greenleaf, David R. Walt, and Curtis Layton. The company specializes in commercializing disruptive technology for therapeutic antibody and binder discovery. The company's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run, enabling the identification of better antibody candidates on an exponentially faster timeline compared to current state-of-the-art antibody discovery and optimization techniques that may take months of laborious laboratory procedures executed by highly-skilled practitioners. Curtis Layton has been the CEO since 2019. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Epinomics, Inc.
![]() Epinomics, Inc. Packaged SoftwareTechnology Services Epinomics, Inc. provides decoding programming of genome to drive personalized medicine. The company was founded by Paul Giresi, Fergus Chan, Howard Y. Chang and Will Greenleaf and is headquartered in Menlo Park, CA. | Technology Services |
Protillion Biosciences, Inc.
![]() Protillion Biosciences, Inc. BiotechnologyHealth Technology Protillion Biosciences, Inc. is a company based in Burlingame, CA that was founded in 2019 by Will Greenleaf, David R. Walt, and Curtis Layton. The company specializes in commercializing disruptive technology for therapeutic antibody and binder discovery. The company's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run, enabling the identification of better antibody candidates on an exponentially faster timeline compared to current state-of-the-art antibody discovery and optimization techniques that may take months of laborious laboratory procedures executed by highly-skilled practitioners. Curtis Layton has been the CEO since 2019. | Health Technology |
- Borsa valori
- Insiders
- Will Greenleaf